Drug rebate agreements pursuant to § 130a(8) SGB V in the context of open house procedures
Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren
Germany · Dresden · how to bid here →
Your path to submission
- Deadline: 5 May 2027 at 08:00 — 210 days left.
- The submission point is stated in the notice (link on the right).
- Offer and evidence in: DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU.
- Collect your evidence — use the eligibility analysis above: it lists the requirements and, for known certificates, how to get them.
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every 2 months (1000 awards, most recently September 2026) — the next award is due around November 2026 by that rhythm. The last award went to G.L. Pharma Deutschland GmbH.n = 1,000
- 66% of this buyer's awards went to companies that had already won here before (1,776 awards since 2018, spread over 607 companies). 34% went to new names.n = 1,776 awards since 2018
- The award came in at a median 70% of the estimated value (7 awards with both estimate and value) — pricing at the estimate is usually too high here. Sector: 87%.n = 7
- The median procedure drew 2 bids (1,748 procedures with a bid count); 43% ended with a single bidder. Sector: median 2 bids.n = 1,748
- < 1% of the bids received came from other countries (141 procedures with a bid mix) — all bidders, not just the winners. Sector: 5%.n = 141
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 06/10/2026.
Foreign bidders
In Germany · Medical equipment & pharma, 265 contracts went to foreign companies over the last 3 years (of 22,200 recorded awards) — mostly from Austria, Netherlands, France.
Submission language: DEU.
Typical field: median 17 (from 1,477 awards).
What the buyer is looking for
Adalimumab; without 80 mg; ATC code: L04AB04 · Adalimumab; 80 mg; ATC code: L04AB04 · Atovaquon and Proguanil; ATC code: P01BB51 · betamethasone; ATC code: H02AB01 · Cefixim; film-coated tablets; ATC code: J01DD08 · Ciclesonide; ATC code: R03BA08 · Cobimetinib; ATC code: L01EE02 · codeine and paracetamol; ATC code: N02AJ06 · Darifenacin; ATC code: G04BD10 · Denosumab; 60 mg; ATC code: M05BX04 · Denosumab; 120 mg; vials; ATC code: M05BX04 · Denosumab; 120 mg; pre-filled syringes; ATC code: M05BX04 · doxylamin and pyridoxine; ATC code: R06AA59 · Electrolyte solutions; ATC code: B05XA · Empagliflozin; ATC code: A10BK03 · Estradiol; Plaster transdermal; ATC code: G03CA03 · Felbamat; ATC code: N03AX10 · Fluorouracil; cream; ATC code: D11AF05 (ADV); L01BC02 (WHO · Follitropin alfa; ATC code: G03GA05 · Follitropin beta; ATC code: G03GA06 · Glucagon; ATC code: H04AA01 · Goserelin; ATC code:…
Show full description
… L02AE03 · isosorbide mononitrate; ATC code: C01DA14 · Lapatinib; ATC code: L01EH01 · Leuprorelin; ATC code: L02AE02 · mesalazine; without suppositories; without tablets gastric-resistant 500 mg; ATC code: A07EC02 · Mycophenolic acid; potency 1 g; ATC code: L04AA06 · Peginterferon alfa-2a; ATC code: L03AB11 · polystyrene sulfonate; ATC code: V03AE01 · Sarilumab; ATC code: L04AC14 · sulfamethoxazole and trimethoprim; ATC code: J01EE01 · Tapentadol; film-coated tablets; ATC code: N02AX06 · Tranylcypromine; ATC code: N06AF04 · Umeclidinium; ATC code: R03BB07 · Zuclopenthixol; ATC code: N05AF05
What you must prove — eligibility criteria
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Abacus Medicine A/S · Kopenhagen | 59 | 2015–2026 |
| EurimPharm Arzneimittel GmbH · Saaldorf-Surheim | 50 | 2016–2026 |
| CC Pharma GmbH · Densborn | 42 | 2012–2023 |
| kohlpharma GmbH · Merzig | 40 | 2014–2023 |
| Aliud Pharma GmbH · Laichingen | 36 | 2011–2023 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.